Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725185) titled 'Effects of Remimazolam on Postoperative Myocardial Injury' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Care Provider).
Primary Sponsor: Affiliated Hospital of Jiaxing University
Condition:
Myocardial Injury
Intervention:
Drug: Remimazolam
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 1, 2026
Target Sample Size: 80
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07725185
Published by HT Digital Content S...